HIV Treatment Bulletin - Vol. 6, No. 9, September 2005

This issue of HTB reports from the 3rd IAS Conference on HIV Pathogenesis and Treatment that was held in Rio this summer and includes paediatric studies, strategies for prevention of mother-to-child transmission, the management of treatment experienced patients, a review of new drugs in the pipeline, and an overview of pharmocology and drug-drug interaction studies.

Closer to home, the UK 2005 BHIVA Guidelines are now posted to their website. As a review of the latest evidence-based medicine, this extensively revised edition are essential reading for healthcare providers, advocates, funders and patients.

They constitute management guidelines for a minimum recommended standard of care in the UK. We have included a summary of some of the main new recommendations together with the appropriate web link.

We have also included two recent statements from the European regulatory agency, related to risk of cardiovascular complications, and use of antiretroviral drug on patients who are coinfected with viral hepatitis.

The research commissioned following these regulatory concerns involved a unique collaboration between pharmaceutical companies and independent investigators over many years that is to be commended. Data will continue to be collected at least in the short term regarding cardiovascular risk, although as the indicated in the second EMEA statement, this group will increasingly focus on use of antiretroviral drugs in patients with HIV and hepatitis coinfection.

050910
IB050609-01

©2005. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone / Firestone Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.